Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The duodenal microbiota refers to the complex community of microorganisms residing in the duodenum, the first section of the small intestine. Unlike the dense colonic microbiota, the duodenal environment is characterized by rapid transit, low pH, and high bile concentrations, leading to a distinct microbial profile dominated by Firmicutes and Actinobacteria (Leite et al., 2020; Kastl et al., 2020). This community plays a critical role in host health by facilitating nutrient absorption, synthesizing essential vitamins, and modulating the mucosal immune response (Kastl et al., 2020). Alterations in its composition, known as dysbiosis, are linked to various gastrointestinal and systemic conditions, including Small Intestinal Bacterial Overgrowth (SIBO), celiac disease, and metabolic disorders like Type 2 diabetes (Zhong et al., 2020; Saffouri et al., 2019). Therapeutic strategies targeting the duodenal microbiota include non-absorbable antibiotics like rifaximin, probiotics, and dietary interventions aimed at restoring homeostatic balance and improving metabolic health (Pimentel et al., 2011; Saffouri et al., 2019). Understanding the duodenal microbiota is increasingly important for developing precision medicine approaches for gastrointestinal and systemic metabolic diseases.
Modulation of microbial diversity and abundance to restore metabolic homeostasis, reduce mucosal inflammation, and regulate bile acid signaling pathways (Pimentel et al., 2011; Saffouri et al., 2019).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Duodenal microbiota.